Trends and Costs of Minimally Invasive Surgery for Kidney Cancer in the US: A Population-based Study

• Published in: Urology (Ridgewood, N.J.) N.J.), 2024-07, Vol.189, p.41-48
• Main Authors: Ditonno, Francesco, Franco, Antonio, Manfredi, Celeste, Sturgis, Morgan R., Feng, Carol L., Roadman, Daniel F., Mossak, Spencer M., Bologna, Eugenio, Licari, Leslie Claire, De Nunzio, Cosimo, Corsi, Nicholas J., Rogers, Craig, Abdollah, Firas, Antonelli, Alessandro, Cherullo, Edward E., Olweny, Ephrem O., Autorino, Riccardo
• Format: Article
• Language: English
• ISSN: 0090-4295; 1527-9995; 1527-9995
• DOI: 10.1016/j.urology.2024.03.038

To analyze temporal trends and costs associated with the use of minimally invasive surgery (MIS) for kidney cancer in the US over the past decade. To examine the impact of social determinants of health (SDOH) on perioperative outcomes. The PearlDiver Mariner, a national database of insurance billing records, was queried for this retrospective observational cohort analysis. The MIS population was identified and stratified according to treatment modality, using International Classification of Diseases and current procedural terminology codes. SDOH were assessed using International Classification of Diseases codes. Negative binomial regression was used to evaluate the overall number of renal MIS and Cochran-Armitage tests to compare the utilization of different treatment modalities, over the study period. Multivariable logistic regression analysis identified predictors of perioperative complications. A total of 80,821 MIS for kidney cancer were included. Minimally invasive partial nephrectomy adoption as a fraction of total MIS increased significantly (slope of regression line, reg. = 0.026, P